Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6616 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-15 (pharmiweb.com)
Growth Prospects of Biotechnology Market Expected to Reach USD 7.417 Trillion by 2035 -
The Global Biotechnology Market is valued at USD 1.77 Trillion in 2024 and is projected to reach a value of USD 7.417 Trillion by 2035 at a CAGR (Compound Annual Growth Rate) of 13.95% over the forecast period 2025-2035.Market OverviewThe industry is being propelled by significant government support in the form...
Read more
2025-03-20 (biopharmadive.com)
Novartis builds case for new SMA gene therapy |
To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as Zolgensma, could be approved for a broad range of spinal muscular atrophy patients.
Read more
(marketbeat.com)
5 Biotech stocks tapping into unmet mental health treatment needs
Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.
Read more